April 4, 2022
Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa
The present work details the development of an oral solid dosage form to address
the rare disease epidermolysis bullosa, which can appear already in newborn
children. Full paper available in the PAPERS section.
Find others papers here and learn about
- Transfer and scale-up of the manufacturing of orodispersible mini-tablets from a compaction simulator to an industrial rotary tablet press
- QbD approach formulation design for metformin HCI and evaluations
- Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions
#STYL'One
#stability
#epidermolysis bullosa
#losartan potassium
#dry granulation
#paediatrics
#rare disease
#mini-tablets
#coating